These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31982663)

  • 1. Why do multiple sclerosis and migraine coexist?
    Hamamcı M; Göcmen AY; Say B; Alpua M; Badem ND; Ergün U; Ertuğrul İnan L
    Mult Scler Relat Disord; 2020 May; 40():101946. PubMed ID: 31982663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum paraoxonase and arylesterase activity and oxidative status in patients with multiple sclerosis.
    Kirbas A; Kirbas S; Anlar O; Efe H; Yilmaz A
    J Clin Neurosci; 2013 Aug; 20(8):1106-9. PubMed ID: 23669169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Delta-Aminolevulinic Dehydratase Activity, Oxidative Stress Biomarkers, and Vitamin D Levels in Patients with Multiple Sclerosis.
    Polachini CR; Spanevello RM; Zanini D; Baldissarelli J; Pereira LB; Schetinger MR; da Cruz IB; Assmann CE; Bagatini MD; Morsch VM
    Neurotox Res; 2016 Feb; 29(2):230-42. PubMed ID: 26690779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysequilibrium of the PTH-FGF23-vitamin D axis in relapsing remitting multiple sclerosis; a longitudinal study.
    Stein MS; Ward GJ; Butzkueven H; Kilpatrick TJ; Harrison LC
    Mol Med; 2018 May; 24(1):27. PubMed ID: 30134801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.
    Muris AH; Rolf L; Broen K; Hupperts R; Damoiseaux J; Smolders J
    J Steroid Biochem Mol Biol; 2016 Nov; 164():254-257. PubMed ID: 26598277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D and disability in relapsing-remitting multiple sclerosis in patients with a Mexican background.
    Rito Y; Flores J; Fernández-Aguilar A; Escalante-Membrillo C; Barboza MA; Amezcua L; Corona T
    Acta Neurol Belg; 2018 Mar; 118(1):47-52. PubMed ID: 28975580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of endogenous antiradical protective system in multiple sclerosis.
    Davitashvili D; Beridze M; Shakarishvili R; Kiziria M; Sanikidze T
    Georgian Med News; 2012 Apr; (205):11-9. PubMed ID: 22665726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress and decreased thiol level in patients with migraine: cross-sectional study.
    Eren Y; Dirik E; Neşelioğlu S; Erel Ö
    Acta Neurol Belg; 2015 Dec; 115(4):643-9. PubMed ID: 25595415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of serum oxidant/antioxidant balance in multiple sclerosis.
    Acar A; Ugur Cevik M; Evliyaoglu O; Uzar E; Tamam Y; Arıkanoglu A; Yucel Y; Varol S; Onder H; Taşdemir N
    Acta Neurol Belg; 2012 Sep; 112(3):275-80. PubMed ID: 22450709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and DNA damage in patients with migraine.
    Geyik S; Altunısık E; Neyal AM; Taysi S
    J Headache Pain; 2016; 17():10. PubMed ID: 26883365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis.
    Choi IY; Lee P; Adany P; Hughes AJ; Belliston S; Denney DR; Lynch SG
    Mult Scler; 2018 Jul; 24(8):1029-1038. PubMed ID: 28569645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Relationship between Antioxidant Enzymes, Oxidative Stress Markers, and Clinical Profile in Relapsing-Remitting Multiple Sclerosis.
    Bizoń A; Chojdak-Łukasiewicz J; Budrewicz S; Pokryszko-Dragan A; Piwowar A
    Antioxidants (Basel); 2023 Aug; 12(8):. PubMed ID: 37627633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Disease-Modifying Therapies on Oxidative Stress in Patients With Relapsing-Remitting Multiple Sclerosis.
    Topic A; Vasic M; Markovic B; Milinkovic N; Dincic E
    Clin Neuropharmacol; 2022 Nov-Dec 01; 45(6):157-161. PubMed ID: 36093923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.
    Røsjø E; Steffensen LH; Jørgensen L; Lindstrøm JC; Šaltytė Benth J; Michelsen AE; Aukrust P; Ueland T; Kampman MT; Torkildsen Ø; Holmøy T
    J Neurol; 2015 Dec; 262(12):2713-21. PubMed ID: 26429571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulatory antioxidant and oxidative stress markers are in correlation with demographics but not cognitive functions in multiple sclerosis patients.
    Naseri A; Forghani N; Sadigh-Eteghad S; Shanehbandi D; Asadi M; Nasiri E; Talebi M
    Mult Scler Relat Disord; 2022 Jan; 57():103432. PubMed ID: 34922253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of S100A12 and Apo-A1 plasma level potency in untreated new relapsing-remitting multiple sclerosis patients and their family members.
    Samangooei M; Farjam M; Etemadifar M; Taheri A; Meshkibaf MH; Movahedi B; Niknam Z; Noroozi S
    Sci Rep; 2022 Feb; 12(1):2160. PubMed ID: 35140322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life assessment in migraine and relapsing remitting multiple sclerosis: self-perceived health is similar.
    Glavor KD; Titlić M; Vuletić G; Mrđen A; Šimunić MM
    Neurol Sci; 2019 Dec; 40(12):2549-2554. PubMed ID: 31317351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab.
    Laursen JH; Søndergaard HB; Sørensen PS; Sellebjerg F; Oturai AB
    Mult Scler Relat Disord; 2016 Nov; 10():169-173. PubMed ID: 27919484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between smoking and total antioxidant status, total oxidant status, oxidative stress index, vit C, vit E.
    Karademirci M; Kutlu R; Kilinc I
    Clin Respir J; 2018 Jun; 12(6):2006-2012. PubMed ID: 29247592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocytes' antioxidative capacity as a potential marker of oxidative stress intensity in neuroinflammation.
    Ljubisavljevic S; Stojanovic I; Cvetkovic T; Vojinovic S; Stojanov D; Stojanovic D; Stefanovic N; Pavlovic D
    J Neurol Sci; 2014 Feb; 337(1-2):8-13. PubMed ID: 24269090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.